{
  "main_header": {
    "sid": 879996,
    "name": "Emmessar Biotech",
    "stock_name": "Emmessar Biotech",
    "full_name": "Emmessar Biotech & Nutrition Ltd",
    "name_url": "stocks-analysis/emmessar-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.48",
    "chg": 0.81,
    "chgp": "3.04%",
    "dir": 1,
    "prev_price": "26.67",
    "mcapval": "14.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524768,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE634B01016",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.14 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/emmessar-biotech-879996-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3745006",
        "imagepath": "",
        "date": "2025-12-04 00:51:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Underperformance Against Benchmarks</strong></p>\n<p>Emmessar Biotech's recent price action is part of a sustained period of weakness relative to the broader market. Over the past week, the stock has declined by 10.03%, a stark contrast to the Sensex's marginal fall of 0.59%. This underperformance extends over longer horizons, with the stock down 6.90% in the last month while the Sensex gained 1.34%. Year-to-date figures reveal a more pronounced divergence, as Emmessar Biotech has lost 37.62% compared to the Sensex's 8.92% gain. Over one year, the stock's decline of 39.30% contrasts sharply with the Sensex's 5.27% increase, underscoring the company's struggles amid a generally rising market.</p>\n<p><strong>Short-Term Price Dynamics and Trading Patterns</strong></p>\n<p>On the day in..."
      },
      {
        "title": "How has been the historical performance of Emmessar Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-emmessar-biotech-3695470",
        "imagepath": "",
        "date": "2025-11-13 00:26:09",
        "description": "Answer:\nThe historical performance of Emmessar Biotech shows significant fluctuations in its financial metrics over the years.\n\nBreakdown:\nEmmessar Biotech's net sales have varied considerably, peaking at 6.99 Cr in Mar'21 before declining to 0.61 Cr in Mar'25. The total operating income followed a similar trend, with a high of 6.99 Cr in Mar'21 and a drop to 0.61 Cr in Mar'25. The company's total expenditure, excluding depreciation, has also seen fluctuations, reaching a high of 6.14 Cr in Mar'21 and decreasing to 1.56 Cr in Mar'25. Operating profit (PBDIT) has been negative in recent years, with a loss of 0.95 Cr in Mar'25, contrasting with a profit of 0.85 Cr in Mar'21. Profit after tax has decreased from 1.45 Cr in Mar'21 to 0.32 Cr in Mar'25. The company's total assets have increased from 5.19 Cr in Mar'20 to 9.22 Cr in Mar'25, while total liabilities have also risen from 5.19 Cr to 9.22 Cr in the same..."
      },
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3693601",
        "imagepath": "",
        "date": "2025-11-12 22:58:18",
        "description": "As of 12-Nov, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.05, reflecting a slight increase of 0.05, or 0.16%. The stock has been gaining for the last two days, with a total return of 3.53% during this period. However, it has underperformed its sector by 0.92% today. In terms of longer-term performance, the stock has experienced a decline of 1.43% over the past month and a significant drop of 32.94% year-to-date. Despite these challenges, there has been a notable increase in investor participation, with delivery volume rising by 405.63% compared to the 5-day average, indicating growing interest in the stock.\n\nIn the broader market context, the Sensex has outperformed Emmessar Biotech, returning 1.21% over the past week and 2.38% over the past month, while the stock has seen negative returns in both timeframes. Year-to-date, the Sensex has gained 8.10%, contrasting sharply with Emmessar'..."
      },
      {
        "title": "When is the next results date for Emmessar Biotech?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-emmessar-biotech-3681227",
        "imagepath": "",
        "date": "2025-11-07 23:20:08",
        "description": "Emmessar Biotech will declare its results on 12 November 2025...."
      }
    ],
    "total": 57,
    "sid": "879996",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/emmessar-biotech-nutrition-879996"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "Please refer attachment",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Dec-2025",
      "details": "Refer attachment",
      "source": "BSE"
    },
    {
      "caption": "Newspaper Add",
      "datetime": "13-Nov-2025",
      "details": "Please refer attachment",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Emmessar Biotech falling/rising?

2025-12-04 00:51:51

Persistent Underperformance Against Benchmarks Emmessar Biotech's recent price action is part of a sustained period of weakness relative to the broader market. Over the past week, the stock has declined by 10.03%, a stark contrast to the Sensex's marginal fall of 0.59%. This underperformance extends over longer horizons, with the stock down 6.90% in the last month while the Sensex gained 1.34%. Year-to-date figures reveal a more pronounced divergence, as Emmessar Biotech has lost 37.62% compared to the Sensex's 8.92% gain. Over one year, the stock's decline of 39.30% contrasts sharply with the Sensex's 5.27% increase, underscoring the company's struggles amid a generally rising market. Short-Term Price Dynamics and Trading Patterns On the day in...

Read More

How has been the historical performance of Emmessar Biotech?

2025-11-13 00:26:09

Answer: The historical performance of Emmessar Biotech shows significant fluctuations in its financial metrics over the years. Breakdown: Emmessar Biotech's net sales have varied considerably, peaking at 6.99 Cr in Mar'21 before declining to 0.61 Cr in Mar'25. The total operating income followed a similar trend, with a high of 6.99 Cr in Mar'21 and a drop to 0.61 Cr in Mar'25. The company's total expenditure, excluding depreciation, has also seen fluctuations, reaching a high of 6.14 Cr in Mar'21 and decreasing to 1.56 Cr in Mar'25. Operating profit (PBDIT) has been negative in recent years, with a loss of 0.95 Cr in Mar'25, contrasting with a profit of 0.85 Cr in Mar'21. Profit after tax has decreased from 1.45 Cr in Mar'21 to 0.32 Cr in Mar'25. The company's total assets have increased from 5.19 Cr in Mar'20 to 9.22 Cr in Mar'25, while total liabilities have also risen from 5.19 Cr to 9.22 Cr in the same...

Read More

Why is Emmessar Biotech falling/rising?

2025-11-12 22:58:18

As of 12-Nov, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.05, reflecting a slight increase of 0.05, or 0.16%. The stock has been gaining for the last two days, with a total return of 3.53% during this period. However, it has underperformed its sector by 0.92% today. In terms of longer-term performance, the stock has experienced a decline of 1.43% over the past month and a significant drop of 32.94% year-to-date. Despite these challenges, there has been a notable increase in investor participation, with delivery volume rising by 405.63% compared to the 5-day average, indicating growing interest in the stock. In the broader market context, the Sensex has outperformed Emmessar Biotech, returning 1.21% over the past week and 2.38% over the past month, while the stock has seen negative returns in both timeframes. Year-to-date, the Sensex has gained 8.10%, contrasting sharply with Emmessar'...

Read More

When is the next results date for Emmessar Biotech?

2025-11-07 23:20:08

Emmessar Biotech will declare its results on 12 November 2025....

Read More

View All News